Tianjin Tianyao Pharmaceuticals(600488.SH) subsidiary received drug GMP compliance inspection results.
Jinyao Pharmaceutical (600488.SH) announced that its subsidiary, Hubei Jinyao Pharmaceutical Co., Ltd. ("Hubei Jinyao"), recently received a "Notice of Hubei Province Drug GMP Compliance Inspection" (No. E GMP2026-90) issued by the Hubei Provincial Drug Administration. The inspection scope covers small volume injections/lincomycin phosphate injections (China Food and Drug Administration Approval No. H20065073).
Tianjin Tianyao Pharmaceuticals (600488.SH) announced that its subsidiary, Hubei Tianjin Tianyao Pharmaceuticals Co., Ltd. (referred to as "Hubei Jinyao"), recently received a "Notice of Hubei Drug GMP Compliance Inspection" (No. Hubei GMP2026-90) issued by the Hubei Provincial Drug Administration. The inspection scope includes small volume injections / lincomycin phosphate injections (national drug standard H20065073).
Related Articles
ZTE Corporation (00763) has not yet repurchased A shares.
PLAYMATES TOYS (00869) bought back 1 million shares for HKD 440,000 on April 2nd.
FUDANZHANGJIANG (01349) subscribed to 3.00 billion yuan of Ping An Bank's structured deposit products.
ZTE Corporation (00763) has not yet repurchased A shares.
PLAYMATES TOYS (00869) bought back 1 million shares for HKD 440,000 on April 2nd.
FUDANZHANGJIANG (01349) subscribed to 3.00 billion yuan of Ping An Bank's structured deposit products.
